Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Stucker, I.
Right arrow Articles by Hemon, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stucker, I.
Right arrow Articles by Hemon, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Vol 28, 829-835, Copyright © 1999 by International Epidemiological Association


ARTICLES

GSTM1, smoking and lung cancer: a case-control study

I Stucker, I de Waziers, S Cenee, J Bignon, A Depierre, B Milleron, P Beaune and D Hemon
Epedemiologic and Statistical Research on Environment and Health, INSERM U 170, Villejuif, France.

BACKGROUND: We conducted a case-control study to examine the risk of lung cancer in relation to GSTM1 polymorphism and cigarette smoking (primarily of black tobacco) in a French population. METHODS: The 611 subjects were 301 incident lung cancer cases and 310 hospital controls. We were able to constitute a DNA bank for 547 subjects (89.5%) and gather detailed information on smoking history for all of them. Results presented here concern 247 cases and 254 controls. RESULTS: Taking non- or light smokers as the reference category, we estimated odds ratios (OR) of 4.2 (95% CI: 2.6-6.7) and 5.2 (95% CI: 3.3-8.3) for the medium and heavy smokers respectively. On the other hand we estimated that the crude OR associating GSTM1 with lung cancer was 1.3 (95% CI: 0.9-1.8). Furthermore our data do not depart significantly from a multiplicative model of the combined effects of smoking and GSTM1 deficiency. CONCLUSIONS: We conclude that smoking and the GSTM1 gene are each a risk factor for lung cancer, and that their combined effect does not differ significantly from that of a multiplicative model.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins
Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis
Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Pisani, P. Srivatanakul, J. Randerson-Moor, S. Vipasrinimit, S. Lalitwongsa, P. Unpunyo, S. Bashir, and D. T. Bishop
GSTM1 and CYP1A1 Polymorphisms, Tobacco, Air Pollution, and Lung Cancer: A Study in Rural Thailand.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 667 - 674.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. Djousse, J. F. Dorgan, Y. Zhang, A. Schatzkin, M. Hood, R. B. D'Agostino, D. L. Copenhafer, B. E. Kreger, and R. C. Ellison
Alcohol Consumption and Risk of Lung Cancer: The Framingham Study
J Natl Cancer Inst, December 18, 2002; 94(24): 1877 - 1882.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Stucker, A. Hirvonen, I. de Waziers, A. Cabelguenne, K. Mitrunen, S. Cenee, E. Koum-Besson, D. Hemon, P. Beaune, and M.-A. Loriot
Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility
Carcinogenesis, September 1, 2002; 23(9): 1475 - 1481.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Benhamou, W. J. Lee, A.-K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewicz, J. Brockmoller, M. L. Clapper, A. Daly, V. Dolzan, et al.
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk
Carcinogenesis, August 1, 2002; 23(8): 1343 - 1350.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Garte
Metabolic Susceptibility Genes As Cancer Risk Factors: Time for a Reassessment?
Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1233 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Garte, L. Gaspari, A.-K. Alexandrie, C. Ambrosone, H. Autrup, J. L. Autrup, H. Baranova, L. Bathum, S. Benhamou, P. Boffetta, et al.
Metabolic Gene Polymorphism Frequencies in Control Populations
Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1239 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. Stucker, P. Boffetta, S. Antilla, S. Benhamou, A. Hirvonen, S. London, and E. Taioli
Lack of Interaction between Asbestos Exposure and Glutathione S-Transferase M1 and T1 Genotypes in Lung Carcinogenesis
Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1253 - 1258.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Cauchi, I. Stucker, C. Solas, P. Laurent-Puig, S. Cenee, D. Hemon, M. Jacquet, P. Kremers, P. Beaune, and L. Massaad-Massade
Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer
Carcinogenesis, November 1, 2001; 22(11): 1819 - 1824.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. A. Geisler and A. F. Olshan
GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review
Am. J. Epidemiol., July 15, 2001; 154(2): 95 - 105.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.